Related Experiment Video
Updated: May 4, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease
Muriel Girard1, Florence Lacaille, Virginie Verkarre
1Department of Pediatric Gastroenterology and Hepatology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes-Sorbonne Cité, Paris, France; INSERM, UMR 781, Université Paris Descartes-Sorbonne Cité, Institut Imagine, Paris, France.
Unlabelled:
Microvillous inclusion disease (MVID) is a congenital disorder of the enterocyte related to mutations in the MYO5B gene, leading to intractable diarrhea often necessitating intestinal transplantation (ITx). Among our cohort of 28 MVID patients, 8 developed a cholestatic liver disease akin to progressive familial intrahepatic cholestasis (PFIC). Our aim was to investigate the mechanisms by which MYO5B mutations affect hepatic biliary function and lead to cholestasis in MVID patients. Clinical and biological features and outcome were reviewed. Pretransplant liver biopsies were analyzed by immunostaining and electron microscopy. Cholestasis occurred before (n = 5) or after (n = 3) ITx and was characterized by intermittent jaundice, intractable pruritus, increased serum bile acid (BA) levels, and normal gamma-glutamyl transpeptidase activity. Liver histology showed canalicular cholestasis, mild-to-moderate fibrosis, and ultrastructural abnormalities of bile canaliculi. Portal fibrosis progressed in 5 patients. No mutation in ABCB11/BSEP or ATP8B1/FIC1 genes were identified. Immunohistochemical studies demonstrated abnormal cytoplasmic distribution of MYO5B, RAB11A, and BSEP in hepatocytes. Interruption of enterohepatic BA cycling after partial external biliary diversion or graft removal proved the most effective to ensure long-term remission.
Conclusion:
MVID patients are at risk of developing a PFIC-like liver disease that may hamper outcome after ITx. Our results suggest that cholestasis in MVID patients results from (1) impairment of the MYO5B/RAB11A apical recycling endosome pathway in hepatocytes, (2) altered targeting of BSEP to the canalicular membrane, and (3) increased ileal BA absorption. Because cholestasis worsens after ITx, indication of a combined liver ITx should be discussed in MVID patients with severe cholestasis. Future studies will need to address more specifically the effect of MYO5B dysfunction in BA homeostasis.
Insights
Microvillous inclusion disease (MVID), caused by MYO5B gene mutations, can lead to a progressive liver disease resembling PFIC. Impaired MYO5B function disrupts bile flow and increases bile acid absorption, impacting MVID patient outcomes.
Area of Science:
- Hepatology
- Gastroenterology
- Genetics
Background:
- Microvillous inclusion disease (MVID) is a congenital enterocyte disorder linked to MYO5B gene mutations.
- MVID often causes intractable diarrhea, frequently requiring intestinal transplantation (ITx).
- A subset of MVID patients develop a progressive cholestatic liver disease, similar to progressive familial intrahepatic cholestasis (PFIC).
Purpose of the Study:
- To investigate the mechanisms by which MYO5B mutations contribute to hepatic biliary dysfunction and cholestasis in MVID patients.
- To analyze clinical features, outcomes, and liver histology in MVID patients with cholestasis.
- To identify potential therapeutic strategies for MVID-associated cholestasis.
Main Methods:
- Review of clinical and biological data from 28 MVID patients, focusing on 8 with liver disease.
- Analysis of pretransplant liver biopsies using immunostaining and electron microscopy.
- Genetic analysis to rule out mutations in known cholestasis genes (ABCB11/BSEP, ATP8B1/FIC1).
Main Results:
- Cholestasis occurred before or after ITx, characterized by jaundice, pruritus, and elevated bile acids with normal GGT.
- Liver histology revealed canalicular cholestasis, fibrosis, and ultrastructural bile canaliculi abnormalities.
- Immunohistochemistry showed abnormal distribution of MYO5B, RAB11A, and BSEP in hepatocytes, suggesting impaired apical recycling and BSEP targeting.
- Interruption of enterohepatic bile acid cycling provided the most effective long-term remission.
Conclusions:
- MVID patients are susceptible to a PFIC-like liver disease that can negatively impact outcomes post-ITx.
- Cholestasis in MVID arises from impaired MYO5B/RAB11A apical recycling, defective BSEP targeting, and increased ileal bile acid absorption.
- Combined liver-intestinal transplantation should be considered for MVID patients with severe cholestasis, as it can worsen after ITx.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Lysosomal Hydrolases
Cholecystitis
Intralumenal Vesicles and Multivesicular Bodies
Bile
Bile is released when dietary fats enter...

